Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

alectinib

(uh-LEK-tih-nib)
A drug used to treat adults with certain types of non-small cell lung cancer that are ALK positive. It used in patients whose cancer has spread to other parts of the body. It is also used to help keep cancer from coming back in patients whose cancer was removed by surgery. Alectinib is also being studied in the treatment of other types of cancer. Alectinib blocks certain proteins made by the ALK gene, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called Alecensa.
More Information
Search NCI's Dictionary of Cancer Terms